企業プロフィール
Adial Pharmaceuticals 株価・ニュース・カタリスト
- ティッカー:
- ADIL
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
4.99 USD (+25.38%)
終値
最終更新: 2026年8月17日
5.06M USD
時価総額
株価変動の要因
As of Aug 17, 2026, ADIL closed up 25.4% at $4.99. No new same-company headline was identified in the current news window.
企業概要
事業概要
Adial Pharmaceuticals is a clinical-stage biotechnology company focused on treatments for alcohol use disorder and related addiction biology. Its story is centered on the difficult intersection of behavioral health, relapse prevention, and chronic disease management.
所在地とセクター分類
Adial is headquartered in the United States and listed on NASDAQ, with a small-cap specialty-biopharma profile. It sits in addiction medicine rather than mainstream oncology or immunology.
ビジネスモデルの特徴
The business depends on clinical progress, regulatory strategy, and the ability to show that its candidate can create a meaningful treatment option in addiction care. Investors usually watch proof-of-concept data, safety, and commercialization potential.
バイオ業界での位置付け
Adial occupies a niche addiction-medicine position within biotech. The stock is catalyst-sensitive because the company is still trying to prove a focused therapeutic thesis in a difficult indication.
今後のカタリスト
- Adial’s catalyst is AD04 and the alcohol-use-disorder program, where any clinical or regulatory update can keep the story alive. The company still needs a stronger human signal.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。